Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.
This report contains market size and forecasts of Hypersomnia Drug in Global, including the following market information:
Global Hypersomnia Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hypersomnia Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Provigil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hypersomnia Drug include Teva, Jazz Pharmaceuticals, BIOPROJET, AVADEL PHARMACEUTICALS, GlaxoSmithKline, Pfizer, Theranexus, Fisher & Paykel Healthcare and Drive Medical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypersomnia Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypersomnia Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hypersomnia Drug Market Segment Percentages, by Type, 2021 (%)
Provigil
Xyrem
Others
Global Hypersomnia Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hypersomnia Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hypersomnia Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hypersomnia Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypersomnia Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hypersomnia Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Jazz Pharmaceuticals
BIOPROJET
AVADEL PHARMACEUTICALS
GlaxoSmithKline
Pfizer
Theranexus
Fisher & Paykel Healthcare
Drive Medical
Merck